Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and certain children. As with other drugs, Harvoni can cause side ...

Harvoni (ledipasvir/sofosbuvir) is a brand-name drug that’s prescribed for hepatitis C in adults and some children. Harvoni comes as oral tablets and pellets that ...

As Gilead Sciences (GILD) launches its next generation Hepatitis C pill, Harvoni, Medicaid programs are bracing for another extraordinary wave of costs, with 70 percent of states implementing coverage ...

While still being on the receiving end for the high cost of sofosbuvir, Gilead's combination pill for Hepatitis C (sofosbuvir + ledipasvir) was today approved by the FDA. The FDA today approved ...

A $100 million ad blitz has whipped up patient demand for Harvoni, the $1,100-a-pill hepatitis C treatment, even as the drug’s price has drawn a barrage of lawsuits, state investigations, and sharp ...

Gilead Sciences Inc. GILD announced a label expansion for its blockbuster hepatitis C virus (HCV) drug, Harvoni, for the treatment of chronic hepatitis C patients with advanced liver disease in the ...

Gilead’s next generation hepatitis C pill Harvoni is set to be backed by NICE – and this time NHS England won’t be delaying its funding as it has done with the firm’s other hep C drug Sovaldi. In ...

As announced by Express Scripts (ESRX) through PR Newswire Dec. 12, the program that targets the treatment of patients affected with the hepatitis C virus, called "Hepatitis Cure Value Program," will ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. VIENNA — Patients with genotype 4 and 5 hepatitis C ...

Gilead Sciences consolidated its leading position in the hepatitis C virus (HCV) treatment market this week with approval for wider use of its Harvoni product in the ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Health Canada has issued a Notice of Compliance for Harvoni™ (ledipasvir 90 mg/sofosbuvir 400 mg), the ...

Please provide your email address to receive an email when new articles are posted on . A global economic analysis of pricing of a 12-week duration of treatment with Sovaldi or Harvoni in 30 countries ...